Vincent Gualtieri - Sigma Pharmaceuticals Insider

Sigma Pharmaceuticals Limited -- Australia Stock  

AUD 1.31  0.02  1.55%

General Manager - Wholesale Sales

Mr. Vincent Gualtieri is General Manager Wholesale Sales of Sigma Pharmaceuticals Ltd. He commenced with Sigma in 1996. He managed wholesale sales in Victoria and Tasmania for Sigma before moving into the National Sales Manager role five years ago. Prior to joining Sigma Mr. Gualtieri held the roles of Sales Manager and Administration Manager at Myer.
        
61 3 9215 9215  http://www.sigmaco.com.au

Management Efficiency

The company has return on total asset (ROA) of 4.94 % which means that it generated profit of $4.94 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company has accumulated 96.04 M in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Sigma Pharmaceuticals Limited has Current Ratio of 1.49 which is within standard range for the sector.

Similar Executives

Found 12 records

EXECUTIVE Since

Denis KohDigimatic Group Ltd
N/A
Andrew CliffordPlatinum Capital Limited
2017
Andrew StannardPlatinum Capital Limited
2016
Janna VynokurPlatinum Capital Limited
2015
Joanne JefferiesPlatinum Capital Limited
2016
D GoulletWebster Limited
2015
Amanda ThumDigimatic Group Ltd
N/A
LokWebster Limited
2017
BarnesWebster Limited
2015
B BarryWebster Limited
N/A
Kelly PerkinsNavigator Global Investments Li
N/A
Andrew HancockDiversified United Investment L
1991

Entity Summary

Sigma Pharmaceuticals Limited engages in the wholesale and distribution of pharmaceutical solutions to hospitals and retail pharmacies in Australia. Sigma Pharmaceuticals Limited (SIP) is traded on Australian Securities Exchange in Australia. It is located in Rowville, VIC and employs 14 people.

Sigma Pharmaceuticals Leadership Team

Scott Jones, Executive
Mark Hooper, CEO
Gary Dunne, COO
Christine Bartlett, Director
Raymond Gunston, Director
Richard Church, Executive
David Bayes, Director
Brian Jamieson, Chairman
Claire Latham, Executive
Jackie Pearson, Executive
Susan Morgan, Executive
Kathryn Spargo, Director
Gary Woodford, Executive
Iona MacPherson, CFO
Alan OHara, Executive
Sam Lawson, Executive
Vincent Gualtieri, Executive
Jeffrey Sells, CFO
Richard Harris, Executive
David Manuel, Director

Stock Performance Indicators

Current Sentiment - SIP

Sigma Pharmaceuticals Investor Sentiment
Most of Macroaxis users are at this time bullish on Sigma Pharmaceuticals Limited. What is your outlook on investing in Sigma Pharmaceuticals Limited? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
few hours ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
few hours ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
few hours ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
few hours ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
few hours ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
few hours ago
Traded for 23.82
Also please take a look at World Market Map. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.